image
Amneal Pharmaceuticals, Inc. AMRX
Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
Watchlist
$ 7.19
-2.02 %
$ 3.35 B
Market Cap
-181.75
P/E
BALANCE SHEET
3.5 B ASSETS
0.83%
Growth Rates
1Year 0.83%
3Years -3.85%
5Years -0.91%
7Years 14.68%
10Years 0.00%
3.61 B LIABILITIES
4.59%
Growth Rates
1Year 4.59%
3Years 0.36%
5Years 1.70%
7Years 11.20%
10Years 0.00%
-109 M EQUITY
-552.38%
Growth Rates
1Year -552.38%
3Years -9.23%
5Years -5.63%
7Years 16.49%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Amneal Pharmaceuticals, Inc.
image
Current Assets 1.59 B
Cash & Short-Term Investments 111 M
Receivables 776 M
Other Current Assets 702 M
Non-Current Assets 1.91 B
Long-Term Investments 0
PP&E 524 M
Other Non-Current Assets 1.39 B
3.16 %22.15 %20.04 %14.96 %39.70 %Total Assets$3.5b
Current Liabilities 1.13 B
Accounts Payable 259 M
Short-Term Debt 340 M
Other Current Liabilities 531 M
Non-Current Liabilities 2.48 B
Long-Term Debt 2.25 B
Other Non-Current Liabilities 228 M
7.16 %9.42 %14.70 %62.39 %6.32 %Total Liabilities$3.6b

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 110.6 91.5 26.0 247.8 341.4 151.2 213.4 74.2 27.4 61.1
Short Term Investments 0 2.2 1.8 1.2 1.7 1.1 2.1 1.9 4.4 5.0
Receivables 775.7 645.7 796.9 694.7 639.0 635.9 565.3 351.4 394.8 273.8
Inventory 612.5 581.4 530.7 489.4 490.6 381.1 457.2 284.0 266.2 235.0
Other Current Assets 56.2 91.2 113.3 88.2 45.3 73.6 98.1 62.4 33.4 29.7
Total Current Assets 1 587.8 1 377.9 1 411.8 1 520.1 1 551.5 1 210.2 1 286.6 771.9 726.1 604.6
PP&E 523.7 550.1 589.4 639.0 604.7 609.2 544.1 486.8 407.4 318.8
Intangible Assets 732.4 890.4 1 096.1 1 166.9 1 304.6 1 382.8 1 655.0 44.6 45.9 49.7
Goodwill 597.4 598.6 598.9 593.0 522.8 419.5 426.2 26.4 28.4 29.8
Long Term Investments 0 37.1 85.6 0 0 16.4 0 0 0 0
Other Long Term Assets 60.1 18.4 17.6 20.6 22.3 44.3 67.6 11.3 (481.8) (398.3)
Other Assets 0 0 0 0 0 0 0 0 10.9 11.2
Total Assets 3 501.4 3 472.6 3 799.3 3 939.7 4 006.0 3 665.9 4 352.7 1 341.9 1 218.8 1 014.1
LIABILITIES
Accounts Payable 258.7 143.6 166.8 131.1 153.1 103.0 114.8 70.0 60.0 69.9
Short Term Debt 340.3 227.6 104.6 46.0 57.5 37.0 21.7 89.5 37.0 59.7
Other Current Liabilities 546.9 475.4 481.0 497.6 460.8 401.7 417.3 137.4 128.1 109.5
Total Current Liabilities 1 129.8 846.6 752.8 677.2 676.9 550.4 553.9 296.9 225.1 239.1
Long Term Debt 2 252.9 2 522.9 2 740.5 2 830.0 2 887.4 2 733.0 2 669.7 1 395.3 1 160.5 952.6
Deferred Tax Income 0 0 0 0 0 0 1.2 2.5 0 0
Other Liabilities 228.3 83.1 122.1 65.4 96.8 35.7 231.7 10.3 (0.9) (1.0)
Total Liabilities 3 611.0 3 452.6 3 590.4 3 572.7 3 661.1 3 319.1 3 456.4 1 717.5 1 394.8 1 201.0
EQUITY
Common Stock 3.1 3.1 3.0 3.0 3.0 3.0 3.0 2.7 2.7 2.7
Retained Earnings (607.1) (490.2) (406.2) (276.2) (286.8) (377.9) (20.9) (382.8) (175.2) (182.0)
Other Accumulative Comprehensive Income/Loss (65.5) (32.3) 9.9 (24.8) (41.3) 68 K (7.8) (14.2) 0 0
Total Equity (109.5) 20.0 208.9 367.0 344.9 461.6 1 288.0 (375.6) (175.9) (186.9)
Total Liabilities and Equity 3 501.4 3 472.6 3 799.3 3 939.7 4 006.0 3 665.9 4 352.7 1 341.9 0 0
SHARES OUTSTANDING
Common Shares Outstanding 309.0 175.0 150.9 148.9 149.3 132.1 127.3 114.9 114.9 189.0 189.0